LIG Nex1 Stock Rose Half as Much as the KOSPI Rebound

On July 31, 2026, the KOSPI — South Korea’s main equity index, the rough equivalent of the S&P 500 for Korean large caps — rose 17.91% in a single session. That is the largest one-day gain in its history. On the same day, LIG Nex1 stock went from $450 to $491 (₩641,000 to ₩699,000), a gain of 9.05% (my calculation). Roughly half the index. I wrote those two numbers next to each other and sat with them for a while, because a stock that falls with the market and then recovers at half the market’s pace is telling you something specific about why it fell.

A note on the name first. At its March 31, 2026 shareholder meeting the company renamed itself from LIG Nex1 to LIG Defense & Aerospace, as reported by the Korean trade press. The ticker is unchanged at 079550 and it still trades on the KOSPI board rather than the smaller-cap KOSDAQ. Yet search traffic, brokerage notes and my own head all still say the old name four months later. I use both names in this journal entry, and I think the lag itself is a small piece of evidence: the market has not yet repriced this as a different company.

Contents14 min read

What LIG Nex1 stock did on the day the KOSPI set a record

Start with what happened to the index. According to a tally published by the Korean daily Hankook Ilbo, the KOSPI fell 22.19% over the month of July, the worst drawdown among major global indices. Measured from the 1st to the 30th alone the decline was 34.01%. Then it gained 17.91% on the final session. The same report identified the drivers of that single day: Samsung Electronics up 26.81% and SK Hynix up 29.95%.

What matters to me is the origin of the July selloff. The causes that report lists are semiconductor peak-out fears, worries about slowing AI demand, weakening momentum in memory export pricing, and a dispute over whether AI companies are propping up each other’s funding in circular fashion. Every item on that list is a chip and AI story. Defense is not on it.

And yet defense sold off too. Then, on the day chips reversed the index, defense recovered half as much. That asymmetry is the first thing I locked onto. The portion of a decline that the index caused comes back when the index comes back. The portion that does not come back was never about the index. July was not one drawdown. It was two stacked on top of each other, and the last session of the month pulled them apart for me.

The July drawdown had two layers, not one

Take the layer the index did not cause. A July 13 review of Korean defense names by Investchosun, a Korean capital-markets outlet, noted this stock was down roughly 38% from its three-month high and gave four reasons: large order expectations already priced in, capital rotating toward semiconductors where earnings momentum was clearer, no specific mention of Korean firms coming out of the NATO summit, and the loss of the Canadian submarine competition.

That last item is not new to me. I already ran the numbers on it from the other side when I looked at Hanwha Ocean and the Canadian program. Two Korean defense names, one lost bid, two different holes in two different theses.

The Investchosun piece quotes brokerage staff anonymously rather than named analysts, so I treat it as directional confirmation and not as a source for figures. For the record, the bull points it collected were expected second-quarter improvement, large backlog moving into production, and valuations entering attractive territory; the bear points were reduced institutional incentive to hold defense names and the long gap between an order and a signed contract.

This is not a purely Korean phenomenon either. CNBC reported on May 30 that European defense stocks were cooling off after the military spending boom, with Rheinmetall, Saab and Renk in the frame. I have not independently verified the individual European multiples, so I am not going to carry any of those numbers across into this journal. The direction is enough. What lifted global defense equities through 2024 and 2025 was not company-level earnings so much as the expectation that defense budgets would keep climbing, and the slope of that expectation started to flatten in Europe first. The Korean version of that same flattening may be exactly what I watched on July 31, when chips came back and missiles did not. Reading it as a purely domestic flow problem misses that.

Go back further and there is March 31. Korean wire service News1 reported that defense names dropped hard that day as remarks by President Trump revived expectations of an early end to hostilities, with this stock falling about 10%. Checking daily closes myself, it went from $481 (₩685,000) on March 30 to $427 (₩608,000) on March 31, or −11.24% (my calculation), which is close enough to the reported figure. And the day of that drop was the very shareholder meeting that approved the new name. The company declared itself a global defense and aerospace firm and lost 11% of its market value in the same session. I do not much like coincidences like that, but here it reads less like coincidence and more like structure: this share price responds more to when a war ends than to what the company builds.

An $18.4 billion backlog that refuses to become revenue

Now the company itself. My habit with defense names is to look at backlog first. This stock taught me that habit is wrong.

A February 19, 2026 note from Samsung Securities analyst Han Young-soo, as summarized by the Korean financial daily Money Today, put its finger on it. His year-end 2025 backlog figure was $18.4bn (₩26.2tn), up 31% year on year and 3.2 times the level of five years earlier. The same quarter’s earnings went the other way: fourth-quarter operating profit of $29.6m (₩42.1bn), down 31.8% year on year and roughly 40% below consensus. The cause was about $35m (₩50bn) in loss provisions taken on a large new domestic R&D program. Han’s framing, as the Korean report rendered it, was that the paradoxical root of the weak print was the scale of order wins themselves. He kept a buy rating while cutting his price objective from $418 (₩595,000) to $379 (₩540,000) and lowering full-year 2026 profit estimates by 20%, on the grounds that lengthening delivery schedules on major programs push back when accumulated orders convert into revenue.

I read that a few times. The reason more orders can mean worse profit in a given year is that Korean domestic development contracts reimburse cost while leaving development risk with the contractor. The backlog grows, and at the front end of that backlog the development spending and the provisions go out first. The market prices the headline backlog. The accounting recognizes the early costs. That timing gap is the real engine under this share price, and it is not a one-off — it is what the structure does every time a big domestic program lands.

Why LIG Nex1 stock hinges on export share, not backlog size

The same note carries the other side. Han wrote that exports make up 55% of total backlog and carry superior margins, and that facility expansion continues. Which means that $18.4bn should never be read as one number. It should be read as two: the domestic development block and the export block.

So here is how I would state the moat. The technology moat is real. The profit moat, however, lives only in the export block, not in the backlog as a whole. Holding the development mandate for Korea’s indigenous guided weapons is close to a regulatory moat with an extremely high barrier to entry, but that business is not where the money is made. The margin appears at the moment a system developed at home is sold abroad. Development is the cost; export is the recovery. Which is why, on this name, backlog growth is not automatically good news, and the ratio I actually track is whether export share inside the backlog is rising.

The evidence that exports do produce margin is already on the tape. A May 11, 2026 company brief from Meritz Securities analyst Lee Ji-ho reported first-quarter operating profit of $120m (₩171.1bn), up 56.1% year on year, at a 14.7% operating margin — some 46% above consensus. His attribution was UAE-bound defense exports plus high-margin spare parts. Full-year 2025 operating margin was 7.42%. One quarter came in at 14.7%. That is double.

Behind that sits Iraq. In September 2025 Korean media reported a Cheongung-II export contract with Iraq worth $2.61bn (₩3.71tn). The same air-defense system going out repeatedly to the Middle East matters more than the headline value, because repeat exports run off a line whose development cost has already been recovered. The margin structure on the second sale is not the margin structure on the first.

This is where the global peer frame actually helps me, and it is not the frame most people reach for. The instinct is to compare a Korean missile maker to RTX, because both build air-defense interceptors and Cheongung-II is routinely described in Korean coverage as a system positioned against the Patriot. But RTX sells into the largest domestic defense budget on earth; its home market is the profit pool. The closer analogue is Kongsberg Gruppen of Norway, which developed NASAMS for a small home military and then made its money exporting that system to allied buyers. Same shape as this company: a domestic mandate that pays for development and an export book that pays for everything else. Rheinmetall, on the CNBC list above, sits somewhere in between with a large European home market that has been expanding fast.

I am deliberately not putting peer multiples in this journal, because I could not verify current figures for Kongsberg or Rheinmetall to a standard I would trust, and a wrong peer multiple is the single easiest way to make an analysis look rigorous while being wrong. What the structural comparison gives me without any numbers is the right question to ask each quarter. For an RTX-shaped business you track the budget. For a Kongsberg-shaped business you track export conversion. This company is Kongsberg-shaped, which is why I keep coming back to the 55% and not to the $18.4bn.

Two price objectives, two base years: reading LIG Nex1 stock two ways

The interesting part is that those two notes look at the same company and land two times apart. Meritz: buy, $808 (₩1,150,000) on May 11. The reference price printed in that note was $590 (₩840,000), and the prior session’s close on May 8 was $589 (₩839,000) — a Monday note written off a Friday close, which is what I would expect. Samsung Securities: buy, $379 (₩540,000) on February 19. A 2.1x spread.

I first read that as optimism against pessimism. Putting the two valuation paragraphs side by side changed my mind. The difference is not temperament. It is the base year.

Meritz anchors on 2028, the year it expects Cheongung-II deliveries to three Middle Eastern customers to peak, applying 34.0x to a 2028 estimated EPS of $24 (₩34,366) — a multiple set 25% above the Korean defense sector average. It pulls 2028 forward and prices it today. Samsung Securities looked at 2026 and saw revenue conversion slipping. Through a 2026 window, backlog rises and profit does not. The two analysts did not see different companies. They saw different years.

Once I saw that, the spread stopped looking like disagreement and started looking honest. Valuation on this name is not a question of what multiple is fair; it is a question of which year’s earnings the multiple gets attached to. Meritz flagged its own risk in the note: without fresh order wins the premium is hard to justify, and near-term volatility is high. Anyone buying 2028 has to sit through the two years in between.

There was an earlier read too. LS Securities analyst Choi Jung-hwan cut his objective from $428 (₩610,000) to $393 (₩560,000) on November 7, 2025, per Korean press, warning that development-related loss provisions and routine development expense would cluster in the fourth quarter. Three months later Samsung Securities confirmed exactly that $35m provision. I find that reassuring in an odd way: the earnings volatility on this name is not the unforecastable kind. It has repeated often enough that a named analyst called it a quarter in advance.

Where I stand on LIG Nex1 stock and what I am watching

I do not own this. I will admit that when it printed $404 (₩575,000) intraday on July 30 my hand hovered. From that low to the July 31 close is 21.57% (my calculation), so on outcome alone I missed it. Three reasons I stayed out anyway.

First, on trailing 2025 results this is 60.7x earnings and 10.72x book. A 19.2% ROE is a fine number, but justifying 10x book requires that ROE to hold for years, and I have already watched it break for a quarter.

Second, I do not yet know whether the 14.7% first-quarter operating margin is structure or event. It may be what a specific UAE delivery window produced. When the full prior year ran at 7.42% and one quarter prints 14.7%, my prior is mean reversion until shown otherwise.

Third, that half-sized rebound bothers me. A stock that captures half the upside on a record index day does not, in my experience, capture half the downside when the index wobbles again. It usually works the other way.

The dividend is not a floor here

My usual way of holding a name through a drawdown is to let the dividend buy me time. That tool does not work on this one.

Per Korean regulatory filings, dividend per share ran $1.05 (₩1,500) in 2022, $1.37 (₩1,950) in 2023, $1.69 (₩2,400) in 2024 and $2.07 (₩2,950) in 2025 — three consecutive increases at a 25.3% three-year growth rate. This is a company that raises its dividend. And yet the yield on the July 31 close is 0.42%. The payout nearly doubled in three years while the share price ran faster, which means that at today’s price the dividend is not a cushion under a decline.

I do not read that as a negative signal. Low yield is normal for a company in its growth phase. I record it because it tells me my own method does not apply: this is not a name I can hold and wait on the way I did when I worked through Samsung Fire on Korea’s crash day. Here I have to be shown the earnings before I own it.

What the June 16 upper wick left behind

One more thing from the price series. On June 16, the closing high, this traded up to $771 (₩1,098,000) intraday and finished at $710 (₩1,011,000) — an upper wick giving back 7.92% (my calculation) from the high. Volume that day was 928,561 shares, the heaviest daily figure since the start of June. Heavy volume plus an upper wick means the supply that wanted out at that level actually got out.

The July 31 close of $491 (₩699,000) sits below its 20-day ($504 / ₩717,400), 60-day ($555 / ₩790,900) and 120-day ($531 / ₩756,358) moving averages, all three. The 60-day line is 13.15% (my calculation) above. That the stock is still in that position after a 9% day matters more to me than the size of the bounce. Foreign ownership stands at 26.19% — enough that overseas holders have not walked away, not enough that their flows alone set direction.

So my stance is to wait, in a defined order rather than vaguely.

First, the next quarterly print. If operating margin holds double digits, the first quarter was structure rather than event and my second objection disappears. If it reverts to the 7–8% range, that quarter was a one-off UAE delivery and I shelve this for at least two more quarters.

Second, provisions on new domestic R&D programs. This is where I learn whether the $35m in the fourth quarter of 2025 was the last of it or a recurring cost that arrives with every large domestic win. If it recurs, backlog growth keeps eating profit, and I stop reacting to backlog headlines on this name entirely.

Third, price. The July 29 close of $432 (₩615,000) and the July 30 intraday low of $404 (₩575,000) are the levels the market actually paid during this decline. If that zone reopens before either of the first two questions is answered, I start very small there and only there — not buying without confirmation, but responding to price if price arrives before confirmation does.

Worth adding that the KOSPI itself is not in a normal regime right now. In a market that drops 22% in a month and gains 18% in a day, single-stock signal and index noise are hard to separate. In the same Hankook Ilbo piece, Yuanta Securities put an August KOSPI floor around 5,150 with the range lifting toward 6,350, while Shinhan Investment framed 6,500–6,600 as fair value with 7,200 as first resistance. Even the index calls are that far apart. In a regime like this I would rather add items to my watchlist than add conviction — which is the same conclusion I reached when I looked at Hanwha Aerospace after its 42% correction, and it is a little uncomfortable to notice I have now written the same sentence about two Korean defense names in a row.

If you are reading this from outside Korea

There is no US-listed ADR for this company. Exposure means buying 079550 directly on the KRX, which for most US-based investors means a broker with Korean market access such as Interactive Brokers, and accepting won settlement plus the FX exposure that comes with it. The passive alternatives — the MSCI South Korea ETF (EWY) and the FTSE Korea ETF (FLKR) — hold the Korean large-cap complex broadly, so a defense name of this size shows up as a small weight rather than as an expression of this specific thesis. That distinction matters here more than usual, because the whole argument above is about export share inside one company’s backlog, and an index wrapper does not let you own that.

Where that leaves me: the technology and the export pipeline are real, and the $2.61bn Iraq contract plus a 14.7% first-quarter margin are the proof. What takes time is the trip from those facts to the income statement, and Samsung Securities priced that trip as 2026 delay while Meritz priced it as a 2028 peak. I am sitting between the two calculations, waiting to see which one the next quarter’s numbers support before I move.

Related reading

• Hanwha Aerospace Stock Fell 42%
• Hanwha Ocean Stock After the Canada Submarine Loss